NPPA issued a notification regarding the fixation of retail price of bilayered tablet

Aug 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 25, 2024, issued a notification regarding the fixation of the retail price of bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Vildagliptin IP 100mg (as sustained release) + Metformin Hydrochloride IP 1000mg (as sustained release).

The following has been stated: -

•For each Film-coated tablet contains: bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Vildagliptin IP 100mg (as sustained release) + Metformin Hydrochloride IP 1000mg (as sustained release) ) for M/s Synokem Pharmaceuticals Ltd (Manufacturer) & M/s Blue Cross Laboratories Ltd (Marketer) the retail price is 11.70.

The detailed notification is given in the document attached below.

[Notification No. 19(4153)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT